Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tagging and Fusion Proteins

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mutation of Spirulina sp. by nuclear irradiation to improve growth rate under 15% carbon dioxide in flue gas.

Bioresource technology·2017

Same author

Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection.

The American journal of emergency medicine·2017

Same author

The enhancement mechanism of wine-processed Radix Scutellaria on NTG-induced migraine rats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2017

Same author

Studies on the metabolites difference of psoralen/isopsoralen in human and six mammalian liver microsomes in vitro by UHPLC-MS/MS.

Journal of pharmaceutical and biomedical analysis·2017

Same author

Rhodium(III)-Catalyzed Annulative Carbooxygenation of 1,1-Disubstituted Alkenes Triggered by C-H Activation.

Chemistry (Weinheim an der Bergstrasse, Germany)·2017

Same author

Corynebacterium defluvii sp. nov., isolated from Sewage.

Journal of microbiology (Seoul, Korea)·2017

Search research articles

Related Experiment Video

Updated: Jul 6, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

Progress in the controllability technology of PROTAC.

Xin He¹, Zhibing Weng¹, Yi Zou²

¹School of Chemical and Pharmaceutical Engineering, Changzhou Vocational Institute of Engineering, Changzhou, 213164, PR China.

European Journal of Medicinal Chemistry

|December 31, 2023

Summary

This summary is machine-generated.

Proteolysis-targeting chimaera (PROTAC) technology degrades disease-causing proteins. Researchers are developing controllable PROTACs to minimize toxic side effects and enhance targeted drug delivery for improved therapeutic outcomes.

Keywords:

CRBN Controllability PROTACs Release the active molecule VHL

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Related Experiment Videos

Last Updated: Jul 6, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Area of Science:

Biochemistry
Molecular Biology
Pharmacology

Background:

Proteolysis-targeting chimaera (PROTAC) technology offers a novel mechanism for protein degradation with significant therapeutic potential.
The most advanced PROTAC drug is currently in Phase III clinical trials, indicating rapid development in the field.
While PROTACs have advantages over traditional inhibitors, potential toxic side effects from non-specific protein degradation necessitate further research.

Purpose of the Study:

To comprehensively review current control strategies for Proteolysis-targeting chimaera (PROTAC) technology.
To provide a theoretical foundation for the innovative application of controllable PROTACs.
To address the challenge of minimizing adverse reactions associated with PROTAC-mediated protein degradation.

Main Methods:

Literature review of existing research on Proteolysis-targeting chimaera (PROTAC) technology.
Analysis of various control strategies for targeted drug release and reduced toxicity.
Synthesis of information on the event-driven mode of action of PROTACs.

Main Results:

PROTACs utilize a unique mechanism to induce targeted protein degradation.
Controllable PROTACs are being developed to enhance safety and efficacy.
Diverse strategies exist for achieving targeted release and minimizing off-target effects.

Conclusions:

Control strategies are crucial for the safe and effective clinical application of PROTAC technology.
Further research into controllable PROTACs will expand their therapeutic applications.
This review provides a basis for future innovations in PROTAC-based therapeutics.